JPH3 Gene: Junctophilin-3 and Its Role in Huntington's Disease-Like 2

A comprehensive biomedical overview of JPH3, its genomic context, expression, mutations, and associated disorders.

Gene Information Card

Symbol JPH3
Full Name junctophilin 3
Gene Type protein coding
Chromosomal Location 16q24.3
NCBI Gene ID 57338 ncbi.nlm.nih.gov/gene/57338
Ensembl ID ENSG00000154188
UniProt ID Q9UBC5
OMIM ID 605268
HGNC ID 14203
Aliases JP-3, JP3, HDL2, C16orf26

Description

The JPH3 gene encodes junctophilin-3, a protein that plays a crucial role in the formation of junctional membrane complexes between the plasma membrane and the endoplasmic/sarcoplasmic reticulum. These complexes are essential for excitation-contraction coupling in muscle cells and for calcium signaling in neurons. JPH3 is primarily expressed in the brain, particularly in the striatum and cortex, and is involved in maintaining intracellular calcium homeostasis. Mutations in JPH3, specifically an expanded CAG/CTG repeat in the 5' region, cause Huntington's disease-like 2 (HDL2), a rare autosomal dominant neurodegenerative disorder with clinical features similar to Huntington's disease.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Huntington's disease-like 2 (HDL2) Expansion of a CAG/CTG repeat in the 5' untranslated region of JPH3, leading to a toxic gain-of-function at the RNA level and/or altered protein function, resulting in neurodegeneration. OMIM: 605268; ClinVar: Pathogenic variants; multiple studies (e.g., Holmes et al., 2001; Margolis et al., 2001)
Neurodegeneration with brain iron accumulation (NBIA) - possible association Altered JPH3 expression or function may contribute to iron accumulation and neuronal death, though the exact mechanism is not fully established. Limited evidence; some case reports and studies suggest a link, but not confirmed in large cohorts.

Expression Profile

Tissue Expression
Tissue nTPM level
Brain - cortex 8.2 Medium
Brain - basal ganglia 7.5 Medium
Brain - cerebellum 6.1 Low
Heart 3.4 Low
Skeletal muscle 2.8 Low
Testis 1.5 Not detected
Cell Line Expression
Cell Line nTPM Notes
SH-SY5Y (neuroblastoma) 5.3 Neuronal model, moderate expression
U-87 MG (glioblastoma) 4.1 Low expression
HepG2 (hepatocellular carcinoma) 0.8 Very low expression
A549 (lung carcinoma) 0.5 Not detected
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
CAG/CTG repeat expansion (normal: 6-28; pathogenic: >40) Repeat expansion Rare (prevalence <0.1% in general population) Toxic RNA gain-of-function; altered protein interactions; neurodegeneration
c.1-105CAG repeat (5' UTR) Repeat expansion Pathogenic in HDL2 Disrupts translation and/or RNA processing
Missense variants (e.g., p.Arg112Cys) Missense Unknown frequency Potential loss of protein function; not clearly pathogenic
Mutation functional classification

Loss of Function (LOF)

Loss of JPH3 function may impair calcium signaling and membrane junction formation, but haploinsufficiency is not the primary mechanism for HDL2; complete loss is not observed in patients.

Gain of Function (GOF)

The expanded CAG/CTG repeat produces a toxic RNA that sequesters RNA-binding proteins (e.g., MBNL1), leading to splicing defects and neuronal toxicity. This is the primary pathogenic mechanism.

Dominant Negative (DN)

The mutant RNA or protein may interfere with the function of the normal allele, but evidence for a dominant-negative effect is limited.

Pathways

Calcium signaling pathway (Reactome: R-HSA-4086398)
Excitation-contraction coupling (Reactome: R-HSA-5576891)
Neurodegeneration pathways (KEGG: hsa05016)

Protein Summary

Junctophilin-3 is a 748-amino acid protein with a molecular weight of approximately 85 kDa. It contains a C-terminal transmembrane domain that anchors it to the endoplasmic/sarcoplasmic reticulum membrane, and an N-terminal domain that interacts with the plasma membrane. The protein forms junctional membrane complexes that are critical for the close apposition of the ER/SR and the plasma membrane, facilitating calcium release and signaling. In neurons, JPH3 is involved in calcium homeostasis, synaptic plasticity, and neuronal survival. Mutations in JPH3, particularly the CAG/CTG repeat expansion, lead to a toxic RNA that disrupts RNA processing and contributes to neurodegeneration in HDL2.

Related Products

Product name Cat.No. Species Gene ID
JPH3 Knockout HEK293 Cell Line EDJ-KQ13883 Human 57338 Details Get a Quote
JPH3 Knockout HeLa Cell Line EDJ-KQ43738 Human 57338 Details Get a Quote
JPH3 Knockout A-549 Cell Line EDJ-KQ65338 Human 57338 Details Get a Quote
JPH3 Knockout HCT 116 Cell Line EDJ-KQ73777 Human 57338 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: